Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

9 results about "Sanguinarine" patented technology

Sanguinarine is a toxic polycyclic ammonium ion. It is extracted from some plants, including the bloodroot plant, from whose taxonomic name, Sanguinaria canadensis, its name is drawn; the Mexican prickly poppy (Argemone mexicana), Chelidonium majus, and Macleaya cordata.

Application of chlorsanguinarine in preparation of medicine for treating PRCC-TFE3 rearrangement renal cell carcinoma

PendingCN122005564AOrganic active ingredientsUrinary disorderEfficacyAutocrine signalling
The invention discloses an application of sanguinarine chloride (SGC) in preparation of a medicine for treating a PRCC-TFE3 rearranged renal cell carcinoma (rRCC), and belongs to the technical field of biological medicine, in particular to an application of sanguinarine chloride (SGC) in preparation of a medicine for treating a PRCC-TFE3 rearranged renal cell carcinoma (rRCC). According to the application, it is found for the first time that SGC has a specific killing effect on PRCC-TFE3 rRCC cells and has extremely low toxicity on normal kidney cells; the SGC has multiple anti-tumor action mechanisms: on one hand, the SGC is directly combined with and antagonizes a VEGFR2 receptor on a cell membrane to block autocrine signal transduction of VEGFB; on the other hand, the SGC inhibits transcription of VEGFB (vascular endothelial growth factor B) through ROS / p-STAT3 axis epigenetics; besides, the SGC can inhibit the production of lactic acid and the acylation of H3K18, and down-regulate the secretion of chemotactic factors, so that the infiltration of polymorphic myeloid-derived suppressor cells (PMN-MDSCs) in a tumor microenvironment is remarkably inhibited; in an immune sound mouse model, the SGC shows an excellent in-vivo anti-tumor effect, and a brand new targeting and immunoregulation double-effect candidate drug is provided for clinically treating the PRCC-TFE3 rRCC lacking an effective standard therapy.
Owner:NANJING DRUM TOWER HOSPITAL

Application of sanguinarine in preparation of medicine for preventing and treating fatty liver or obesity

The invention discloses application of sanguinarine in preparation of a medicine for preventing and treating fatty liver or obesity, and belongs to the technical field of medicines. The invention is implemented in vitro and in vivo, and aims to solve the problem of lack of low-toxicity natural small molecule drugs for effectively preventing and treating fatty liver or obesity at present. The embodiment of the invention proves that sanguinarine can obviously reduce high-fat diet induced mouse fat deposition, reduce in-vivo and in-vitro liver TG content and lipid droplet accumulation, enhance glucose tolerance of the high-fat diet induced mouse and improve insulin resistance of the high-fat diet induced mouse. As a natural antioxidant, sanguinarine has an obvious relieving effect on energy metabolism disorder and oxidative stress induced by high fat. As a low-toxicity natural small molecule, sanguinarine can improve glucose and lipid metabolism disorder induced by high fat, is low in price, and has an application prospect in preparation of medicines for preventing and treating fatty liver or obesity.
Owner:THE PEOPLES HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION

Use of sanguinarine in the preparation of a drug for preventing and treating clinical rare fungal-related infectious diseases

ActiveCN116687929Bperformance inhibitionshow inhibitory effectOrganic active ingredientsAntimycoticsPulmonary infectionEfficacy
The present application relates to the application of sanguinarine in the preparation of drugs for preventing and treating rare clinical fungal infection diseases. Apiotrichum mycotoxinivorans has been confirmed to have the ability to infect humans, and current research confirms that the fungus is at least associated with postoperative pulmonary infection and blood infection diseases. Since the above fungus is still a rare clinical pathogenic bacterium, there is no clear and feasible treatment drug at present. Based on the advantages of low toxicity and side effects of natural drugs and mild efficacy, the present application screens natural drugs with bacteriostatic effect, and provides the application of sanguinarine as a fungus inhibitor, which has good clinical application prospect.
Owner:MATERNAL & CHILD HEALTH CARE HOSPITAL OF SHANDONG PROVINCE SHANDONG UNIV

Macleaya cordata recovery prescription medicine for preventing and treating fish nocardia disease as well as preparation method and application of macleaya cordata recovery prescription medicine

The invention discloses a macleaya cordata recovery prescription medicine for preventing and treating fish nocardia disease as well as a preparation method and application of the macleaya cordata recovery prescription medicine. The compound medicine consists of 10 to 30 percent of macleaya cordata alkaloid hydrochloride compound, 5 to 15 percent of chitosan quaternary ammonium salt, 10 to 20 percent of mannan oligosaccharide and a medicinal carrier. The preparation method comprises the following steps: carrying out freezing and heat shock pretreatment on a macleaya cordata raw material, and carrying out ultrasonic-flash synergistic extraction by adopting acidified ethanol; performing concentration, macroporous resin purification and high-speed counter-current chromatography separation on the extracting solution to obtain a high-purity macleaya cordata alkaloid hydrochloride compound; and finally, mixing the compound with chitosan quaternary ammonium salt and a carrier, granulating, and carrying out enteric coating. According to the method, active alkaloids such as sanguinarine and chelerythrine in macleaya cordata can be efficiently extracted and refined. According to the compound medicine, through scientific compatibility, for example, macleaya cordata alkaloid is antibacterial, chitosan quaternary ammonium salt and mannan oligosaccharide are used for enhancing immunity and targeting, the bioavailability is improved by utilizing a modern preparation technology, and the compound medicine has a good effect of preventing and treating fish nocardia disease.
Owner:ZHEJIANG DANSHUI FISHERY RESEARCH INSTITUTE (ZHEJIANG DANSHUI FISHERY ENVIRONMENTAL MONITORING STATION)

Synthesis method and application of a sanguinarine intermediate compound bromide

The present application relates to the field of medicine synthesis, and discloses a synthetic method of a sanguinarine intermediate compound bromide and application thereof. First, compared with the prior art, the synthetic method of the sanguinarine intermediate compound bromide can avoid using a difficult-to-prepare starting material, has short steps, mild reaction conditions, is easy to operate, has low cost, is environmentally friendly, has high yield and high product purity. Secondly, compared with the prior art, the sanguinarine hemisulfate synthesized by using the above bromide as a raw material can greatly reduce the amount of noble metal palladium catalyst, avoid using silver carbonate as an alkali (acid binding agent), and through conventional post-treatment operations such as extraction, beating and concentration, high-purity sanguinarine hemisulfate can be obtained without column chromatography separation.
Owner:NINGBO CHEMGOO PHAMA TECH CO LTD

Pesticide insecticidal composition as well as preparation method and application thereof

The invention relates to a pesticide insecticidal composition and a preparation method and application thereof, and relates to the field of pesticides, the effective components comprise chlorantraniliprole and sanguinarine sulfate, and the weight ratio of chlorantraniliprole to sanguinarine sulfate is 99: 1-1: 99. According to the invention, chlorantraniliprole and sanguinarine sulfate are compounded together, so that pests can be killed to the greatest extent, and meanwhile, crops are stimulated to repair damage, so that the purposes of repairing after pests and rejuvenating are achieved. Subsequent growth of crops is guaranteed, and social value and economic value of stabilizing and increasing yield and improving quality are achieved.
Owner:HEBEI NONGXIN BIOTECHNOLOGY CO LTD

Toxoplasma gondii biomarker and application thereof

PendingCN121915178AOrganic active ingredientsMicrobiological testing/measurementSulfadiazineGondii toxoplasma
The invention belongs to the technical field of biological medicines, and discloses a toxoplasma gondii biomarker and an application thereof in order to solve the technical problem of relatively less research on TgAP2IX-5 regulation of toxoplasma gondii at present, and particularly, a G-quadruplex nucleic acid sequence is formed in a TgAP2IX-5 gene promoter region, and the TgAP2IX-5 gene promoter region is constructed to obtain the toxoplasma gondii biomarker. And screening of toxoplasma gondii-resistant drugs is carried out by taking the synthesized G-quadruplex as a target spot. The screened small molecular ligands sanguinarine and TMPyP4 have obvious effects of inhibiting transcription of the TgAP2IX-5 gene and proliferation of toxoplasma gondii, and the action effect is superior to that of a clinically common therapeutic drug sulfadiazine; and a good treatment effect can be achieved at a relatively low concentration.
Owner:BEIJING SHIJITAN HOSPITAL CAPITAL MEDICAL UNIVERSITY +1

A method for preparing a natural product 6-HHS

The application provides a preparation method of a natural product 6-HHS, which comprises the following steps: reacting a compound 1, sanguinare, with vinylmagnesium bromide to prepare a compound 2; and reacting the compound 2 with borane tetrahydrofuran complex to prepare 6-HHS. The application uses sanguinare as a raw material to prepare the natural product 6-HHS, has a short synthesis route, high synthesis efficiency, a yield of each step is more than 85%, the comprehensive yield of the natural product 6-HHS can reach 76%, and the operation is simple, the purity is high, and the application can provide a simple and efficient way for chemical synthesis of 6-HHS.
Owner:HUNAN UNIV OF CHINESE MEDICINE